
Experience
Eagle Pharmaceuticals’ Cooperation Agreement With Nantahala Capital Management
August 28, 2025
Cooley advised Eagle Pharmaceuticals, a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise, on its cooperation agreement with Nantahala Capital Management, a holder of approximately 38% of Eagle’s outstanding shares.
Related contacts
Related Practices & Industries
Heliogen Announces Sale to Zeo Energy
May 29, 2025
Cooley advised Heliogen, a provider of on-demand clean energy technology solutions, on its definitive agreement with Zeo Energy, a Florida-based provider of residential solar and energy efficiency solutions, representing the culmination of Heliogen’s review of strategic alternatives and pursuant to which Zeo will acquire all of Heliogen’s outstanding equity securities in an all-stock transaction.
Related contacts
Related Practices & Industries
Tenable to Acquire Apex Security
May 29, 2025
Cooley advised Tenable, an exposure management company, on its definitive agreement to acquire Apex Security, an innovator in securing the rapidly expanding artificial intelligence attack surface.
Related contacts
Related Practices & Industries
Poppi Announces $1.95 Billion Sale to PepsiCo
March 17, 2025
Cooley advised VNGR Beverage (doing business as poppi), a fast-growing prebiotic soda brand, on its acquisition by PepsiCo (Nasdaq: PEP) for $1.95 billion, including an additional potential earnout consideration subject to the achievement of certain performance milestones within a specified period after closing.
Related contacts
Related Practices & Industries
Transact Campus Announces $1.6 Billion Sale to Roper Technologies
August 15, 2024
Cooley advised Reverence Capital Partners’ portfolio company Transact Campus, an innovative campus technology and payment solutions company, on a definitive agreement signed by Reverence Capital Partners to sell Transact to Roper Technologies for $1.6 billion.
Related contacts
Related Practices & Industries
Related news and events
Eagle Pharmaceuticals’ Cooperation Agreement With Nantahala Capital Management
Admissions and credentials
New Hampshire
New York
Massachusetts